. "Appendix A: Information Gathering Workshop Agenda." Scaling Up Treatment for the Global AIDS Pandemic: Challenges and Opportunities. Washington, DC: The National Academies Press, 2005.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Scaling Up Treatment for the Global AIDS Pandemic: Challenges and Opportunities
8:45-9:10
The Global Funds’ Lessons Learned Regarding ARV
Drug Scale-up in Resource-Constrained Settings
Dr. Bernhard Schwartlander
Director
Strategic Information and Measurement
Global Fund to Fight AIDS, TB, and Malaria
Geneva, Switzerland
9:10-9:35
The U.S. Emergency Plan for Antiretroviral Scale-up:
The Latest Programmatic Developments
Dr. Joe O’Neil
Deputy Coordinator
Office of the Global AIDS Coordinator
Department of State
Washington, DC
9:35-9:55
General Discussion
9:55-10:15
BREAK
Antecedents
10:15-10:40
Durability of ARV Therapy: U.S. Experience and Its Implications for Resource-Constrained Settings
Dr. Robert Redfield
Cofounder and Director of Clinical Care and Research Division, Institute of Human Virology
University of Maryland
Baltimore, MD
10:40-11:05
A U.S. Clinical Perspective on the Implications of ARV
Resistance for Resource-Constrained Settings
Dr. Steven Deeks
Associate Clinical Professor of Clinical Medicine
University of California, San Francisco
San Francisco, CA
11:05-11:30
Lessons Learned from the Scale-up of ARV Treatment in Brazil
